| Size & multiples | |||
| Market Cap | $826.5M | Enterprise Value | $797.2M |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 11.54× | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | 11.13× | EV/FCF | — |
| FCF Yield | −10.22% | Buyback Yield | — |
| Owner Earnings (TTM) | -$294.6M | Owner Earnings Yield | −35.64% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.37 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 5.87% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | −205.50% | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM -$3.18 · revenue TTM $71.6M · FCF TTM -$84.5M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -8.6% | -7.8% | -34.7%–1.4% | 48 ↓weak |
| Net Margin | -412.9% | -21.2% | -325.3%–7.2% | 23 ↓weak |
| Operating Margin | -449.9% | -34.5% | -552.0%–8.0% | 26 ↓weak |
| ROE | -94.8% | -36.8% | -92.5%–4.5% | 24 ↓weak |
